- Report
- August 2023
- 51 Pages
Israel
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Colombia
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
South Africa
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Germany
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
France
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Turkey
From €538EUR$600USD£460GBP
- Report
- August 2023
- 51 Pages
Canada
From €538EUR$600USD£460GBP
- Report
- June 2023
- 270 Pages
Global
From €2153EUR$2,400USD£1,842GBP
- Report
- March 2023
- 26 Pages
Global
€10990EUR$12,250USD£9,401GBP
- Drug Pipelines
- December 2022
- 148 Pages
Global
From €13452EUR$14,995USD£11,508GBP
- Report
- December 2022
- 66 Pages
Global
From €3140EUR$3,500USD£2,686GBP
- Report
- October 2021
- 180 Pages
United States
From €2243EUR$2,500USD£1,919GBP
- Report
- October 2021
- 70 Pages
United States
From €978EUR$1,090USD£837GBP
- Report
- April 2021
China
From €2332EUR$2,600USD£1,995GBP
- Report
- April 2021
- 85 Pages
United States
From €1165EUR$1,299USD£997GBP
- Report
- January 2020
- 54 Pages
Global
From €1772EUR$1,975USD£1,516GBP
- Report
- March 2019
- 80 Pages
United States
From €1157EUR$1,290USD£990GBP
- Report
- November 2018
- 30 Pages
China
From €1974EUR$2,200USD£1,688GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more